MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1159/000549167

Медицинская библиотека · Cerebrovascular diseases (Basel, Switzerland) · 2025

Association of Angiotensin Inhibitors with Improved Outcome after Acute Intracerebral Hemorrhage: Secondary Analysis of the INTERACT3 Trial.

Parry-Jones Adrian R, Ren Xinwen, Allan Stuart M, Wang Xia, Anderson Craig S, Kasher Paul R

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

UNLABELLED: <p>

Introduction

Drug screening with a zebrafish model of acute intracerebral hemorrhage (ICH) identified a neuroprotective effect of angiotensin converting enzyme inhibitor (ACE-I) drugs. We identified an association of early ACE-I treatment and favorable 90-day functional outcome in participants of the second Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial. We aimed to confirm a relation between angiotensin inhibitors and good outcome in the larger, third INTEnsive care bundle with blood pressure Reduction in Acute Cerebral hemorrhage Trial (INTERACT3) dataset.

METHODS

This is a post hoc analysis of INTERACT3 in patients with ICH surviving to day 7. Associations of early ACE-I or angiotensin-II receptor blocker (ARB) treatment and neurological impairment (National Institutes of Health Stroke Scale [NIHSS] scores) at day 7 and functional recovery (modified Rankin Scale [mRS] scores) at 6 months were tested in multiple regression and ordinal regression models, respectively, with adjustment for confounding variables.

RESULTS

Of 6,692 participants included in analyses, 2,525 (36.2%) received ACE-I/ARB treatment by day 7. Treatment with an ACE-I/ARB (vs. no ACE-I/ARB) was significantly and independently associated with lower NIHSS scores at day 7 (β-coefficient -1.17, 95% confidence interval [CI] -1.59 to -0.74; p < 0.001) and better mRS scores at 6 months (odds ratio 0.83, 95% CI 0.75-0.93; p = 0.0007).

CONCLUSION

Early treatment with an angiotensin inhibitor is associated with improved outcome after ICH. Further research is needed to test for heterogeneity by ACE-I/ARB drug and treatment window to plan a clinical trial in ICH. </p>.

Для цитирования: Parry-Jones Adrian R, Ren Xinwen, Allan Stuart M, Wang Xia, Anderson Craig S, Kasher Paul R. Association of Angiotensin Inhibitors with Improved Outcome after Acute Intracerebral Hemorrhage: Secondary Analysis of the INTERACT3 Trial.. Cerebrovascular diseases (Basel, Switzerland). 2025. DOI: 10.1159/000549167.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.